Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive, Low-dose Intracoronary Recombinant Tissue Plasminogen Activator (tPA) Versus Placebo for Primary PCI in Patients With ST-segment Elevation Myocardial Infarction

NCT03335839 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT03335839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03335839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive, Low-dose Intracoronary Recombinant Tissue Plasminogen Activator (tPA) Versus Placebo for Primary PCI in Patients With ST-segment Elevation Myocardial Infarction
Lead sponsor
Population Health Research Institute
Phase
Phase 3
Overall status
Completed
Start date
April 1, 2018
Completion date
February 12, 2025
Enrollment
210 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction, percutaneous coronary intervention